Many preferred peptides can no longer be compounded by pharmacies for human use as a result of latest FDA regulatory changes. The FDA has moved many of such substances to Category 2 of its Bulk Drug Substances record, citing security challenges or insufficient knowledge, building them ineligible for compounding.As we’ve stated, peptides are a cat